Cargando…
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression
Breast cancer has the highest incidence and mortality in women worldwide. There are 70% of breast cancers considered as estrogen receptor α (ERα) positive. Therefore, the ERα-targeted therapy has become one of the most effective solution for patients with breast cancer. Whereas a better understandin...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997968/ https://www.ncbi.nlm.nih.gov/pubmed/33771975 http://dx.doi.org/10.1038/s41419-021-03607-w |